Cancer Research: New Hope for Pancreatic, Prostate Cancers
As many who are familiar with me may recall, my mother lost her battle with lung cancer approximately 19 months ago. Since that time, whenever I am trolling for news and items that I might be able to write about, I am continually drawn to news items discussing cancer research.
As anyone who is familiar with clinical trials know, there is no guarantee that even exciting therapies will ever make it to market, much less have a positive impact on patients. Still, the research has to start somewhere and science moves at a deliberate pace. As Thomas Edison even famously quipped, even a failure is successful at teaching what is now not possible.
Positive news stories about cancer research and development also provide hope. Cancer has taken far too many lives. With continued, concerted effort, eventually it will be eradicated. Whether that will be in our lifetime…who knows. It certainly won’t be if patent rights continue to erode. Without strong patent rights, there just isn’t going to be the incentive to pursue speculative therapies, drugs and treatments that cost hundreds of millions of dollars to develop and take to market…particularly when so many fail.
In any event, as I was looking for interesting things to write about, I stumbled across a pair of potentially interesting items…one dealing with pancreatic cancer and the other dealing with prostate cancer. For more information on FDA, pharma and biotech law, please also check these PLI resources:
No Comments
01.9.14 | Patent Issues, posts | Gene Quinn